Drug allergy management in Egypt, Sri Lanka and the Caribbean: A qualitative study

Abdulaziz Alqahtani; Parbir Jagpal; Thushara Kudagammana; Pudupakkam K Vedanthan; Kandamaran Krishnamurthy; Seetharaman Hariharan; Reham Mohamed El Shabrawy; Sandeep Maharaj; John Marriott; Mamidipudi Thirumala Krishna

doi:10.1111/cea.14437

Drug allergy management in Egypt, Sri Lanka and the Caribbean: A qualitative study

Abdulaziz Alqahtani^*, Parbir Jagpal, Thushara Kudagammana, Pudupakkam K Vedanthan, Kandamaran Krishnamurthy, Seetharaman Hariharan, Reham Mohamed El Shabrawy, Sandeep Maharaj, John Marriott, Mamidipudi Thirumala Krishna

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

106 Downloads (Pure)

Abstract

There is a huge burden of penicillin allergy labels (PALs) and up to
95% of PALs are inaccurate.1–3 There is an unmet need for allergy
specialists, particularly in low- middle income countries (LMICs),
where there are alarming rates of antimicrobial resistance (AMR). 4,5
A relatively simple method of risk stratification by non-allergy
healthcare professionals (HCPs) employing a computerised decision
support system (CDSS) has been successfully employed in the con-
text of penicillin allergy de-labelling.6
The aim of this study was to gain insights into drug allergy man-
agement pathways as well as the views and perspectives of HCPs
regarding drug allergies in Sri Lanka, Barbados, Trinidad and Tobago
and Egypt. Drug allergy management pathway refers to the systems,
framework and governance underpinning drug allergy labelling and
de-labelling including mechanisms of documentation and counselling
of patients, referral pathways to an allergy specialist and conducting
root cause analysis of serious and/or near-miss adverse drug events

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Clinical and Experimental Allergy
Early online date	11 Dec 2023
DOIs	https://doi.org/10.1111/cea.14437
Publication status	E-pub ahead of print - 11 Dec 2023

Keywords

anaphylaxis
drug allergy
drug allergy de-labelling
drug allergy labelling
drug allergy management
penicillin allergy

Access to Document

10.1111/cea.14437Licence: Creative Commons: Attribution (CC BY)

AlqahtaniA2023DrugFinal published version, 564 KBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{6096470b98cd4e23b709330628623b3b,

title = "Drug allergy management in Egypt, Sri Lanka and the Caribbean: A qualitative study",

abstract = "There is a huge burden of penicillin allergy labels (PALs) and up to95% of PALs are inaccurate.1–3 There is an unmet need for allergyspecialists, particularly in low- middle income countries (LMICs),where there are alarming rates of antimicrobial resistance (AMR). 4,5A relatively simple method of risk stratification by non-allergyhealthcare professionals (HCPs) employing a computerised decisionsupport system (CDSS) has been successfully employed in the con-text of penicillin allergy de-labelling.6The aim of this study was to gain insights into drug allergy man-agement pathways as well as the views and perspectives of HCPsregarding drug allergies in Sri Lanka, Barbados, Trinidad and Tobagoand Egypt. Drug allergy management pathway refers to the systems,framework and governance underpinning drug allergy labelling andde-labelling including mechanisms of documentation and counsellingof patients, referral pathways to an allergy specialist and conductingroot cause analysis of serious and/or near-miss adverse drug events",

keywords = "anaphylaxis, drug allergy, drug allergy de-labelling, drug allergy labelling, drug allergy management, penicillin allergy",

author = "Abdulaziz Alqahtani and Parbir Jagpal and Thushara Kudagammana and Vedanthan, {Pudupakkam K} and Kandamaran Krishnamurthy and Seetharaman Hariharan and {El Shabrawy}, {Reham Mohamed} and Sandeep Maharaj and John Marriott and {Thirumala Krishna}, Mamidipudi",

year = "2023",

month = dec,

day = "11",

doi = "10.1111/cea.14437",

language = "English",

pages = "1--3",

journal = "Clinical and Experimental Allergy ",

issn = "0954-7894",

publisher = "Wiley",

}

TY - JOUR

T1 - Drug allergy management in Egypt, Sri Lanka and the Caribbean

T2 - A qualitative study

AU - Alqahtani, Abdulaziz

AU - Jagpal, Parbir

AU - Kudagammana, Thushara

AU - Vedanthan, Pudupakkam K

AU - Krishnamurthy, Kandamaran

AU - Hariharan, Seetharaman

AU - El Shabrawy, Reham Mohamed

AU - Maharaj, Sandeep

AU - Marriott, John

AU - Thirumala Krishna, Mamidipudi

PY - 2023/12/11

Y1 - 2023/12/11

N2 - There is a huge burden of penicillin allergy labels (PALs) and up to95% of PALs are inaccurate.1–3 There is an unmet need for allergyspecialists, particularly in low- middle income countries (LMICs),where there are alarming rates of antimicrobial resistance (AMR). 4,5A relatively simple method of risk stratification by non-allergyhealthcare professionals (HCPs) employing a computerised decisionsupport system (CDSS) has been successfully employed in the con-text of penicillin allergy de-labelling.6The aim of this study was to gain insights into drug allergy man-agement pathways as well as the views and perspectives of HCPsregarding drug allergies in Sri Lanka, Barbados, Trinidad and Tobagoand Egypt. Drug allergy management pathway refers to the systems,framework and governance underpinning drug allergy labelling andde-labelling including mechanisms of documentation and counsellingof patients, referral pathways to an allergy specialist and conductingroot cause analysis of serious and/or near-miss adverse drug events

AB - There is a huge burden of penicillin allergy labels (PALs) and up to95% of PALs are inaccurate.1–3 There is an unmet need for allergyspecialists, particularly in low- middle income countries (LMICs),where there are alarming rates of antimicrobial resistance (AMR). 4,5A relatively simple method of risk stratification by non-allergyhealthcare professionals (HCPs) employing a computerised decisionsupport system (CDSS) has been successfully employed in the con-text of penicillin allergy de-labelling.6The aim of this study was to gain insights into drug allergy man-agement pathways as well as the views and perspectives of HCPsregarding drug allergies in Sri Lanka, Barbados, Trinidad and Tobagoand Egypt. Drug allergy management pathway refers to the systems,framework and governance underpinning drug allergy labelling andde-labelling including mechanisms of documentation and counsellingof patients, referral pathways to an allergy specialist and conductingroot cause analysis of serious and/or near-miss adverse drug events

KW - anaphylaxis

KW - drug allergy

KW - drug allergy de-labelling

KW - drug allergy labelling

KW - drug allergy management

KW - penicillin allergy

U2 - 10.1111/cea.14437

DO - 10.1111/cea.14437

M3 - Letter

C2 - 38082508

SN - 0954-7894

SP - 1

EP - 3

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

ER -

Drug allergy management in Egypt, Sri Lanka and the Caribbean: A qualitative study

Abstract

Keywords

Access to Document

Fingerprint

Cite this